Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

Item
http://www.wikidata.org/entity/Q33812049
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy.Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected menRelaxation effect of abacavir on rat basilar arteries.Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study.Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women.Short communication: initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimensInflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudineTobacco use and cessation in HIV-infected individualsRelationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy.Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.
P2860

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir

Item
http://www.wikidata.org/entity/Q33812049
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
type
label
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
prefLabel
Early changes in inflammatory ...... apy with abacavir or tenofovir
@ast
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Early changes in inflammatory ...... apy with abacavir or tenofovir
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932